Sequenom Posts 25 Percent Q2 Revenue Growth, Extends Co-Marketing Pact with SensiGen | GenomeWeb
NEW YORK (GenomeWeb News) – Sequenom today said that increased sales of its MassArray system and consumables drove a 25-percent increase in second-quarter revenues to $12.8 million from $10.2 million in the second quarter of 2007.
Harry Stylli, president and CEO of Sequenom, said in a conference call to discuss the company’s financial results that the firm placed around 16 MassArray systems during the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.